We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VALE3:BMFBOVESPAVale S.A. Analysis

Data as of 2026-07-23 - not real-time

R$75.72

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Vale S.A. trades at a price of R$75.72, roughly four‑times its discounted cash‑flow fair value of R$16.28, indicating a substantial overvaluation. The forward price‑to‑earnings ratio of 9.3x suggests earnings are expected to improve, yet the trailing P/E of 22.5x remains elevated. Revenue growth is modest at 2.7% and profit margins sit near 7%, highlighting limited near‑term upside from operations. The dividend yield of 9.2% is attractive, but a payout ratio above 117% raises concerns about sustainability. Technical indicators show a neutral trend: the 20‑day SMA (75.28) sits just below the current price, the 50‑day SMA is higher at 78.77, and the RSI is near 49, while a bullish MACD signal hints at a possible short‑term lift. Volume is on a decreasing trajectory, and price remains confined between a support of 71.57 and resistance near 79.32. The stock’s beta of 0.75 and 30‑day volatility of 26% point to moderate market sensitivity. Vale’s high debt‑to‑equity ratio (~57) and exposure to Brazilian regulatory and ESG scrutiny add layers of risk. Overall, the combination of overvaluation, dividend sustainability concerns, and sector cyclicality suggests caution, while the forward earnings outlook and high yield keep the stock on investors’ radar.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near 20‑day SMA with limited upside to resistance
  • Decreasing volume indicating waning short‑term momentum
  • Bullish MACD histogram despite overall neutral trend

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward EPS growth lowering forward P/E to ~9.3x
  • High dividend yield offset by unsustainable payout ratio
  • Modest revenue growth and thin profit margins

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • DCF fair value far below current market price
  • Elevated debt load and potential ESG/regulatory constraints
  • Commodity‑driven sector cyclicality and Brazil‑specific risks

Key Metrics & Analysis

Financial Health

Revenue Growth2.70%
Profit Margin7.26%
P/E Ratio22.5
ROE6.84%
ROA8.19%
Debt/Equity57.15
P/B Ratio1.7
Op. Cash FlowR$48.8B
Free Cash FlowR$10.6B

Technical Analysis

TrendNeutral
RSI49.0
SupportR$71.57
ResistanceR$79.32
MA 20R$75.28
MA 50R$78.77
MA 200R$76.46
MACDBullish
VolumeDecreasing
Fear & Greed Index86.41

Valuation

Fair ValueR$16.28
Target PriceR$87.92
Upside/Downside16.11%
GradeOvervalued
TypeValue
Dividend Yield9.18%

Risk Assessment

Beta0.75
Volatility26.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.